Ali-el-Dein, B <br/><br/>
Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.  [electronic resource] 

 -  The Journal of urology  Jul 1997 
 - 68-73; discussion 73-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1097/00005392-199707000-00018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Disease Progression<br/>Doxorubicin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--epidemiology<br/>Neoplasm Staging<br/>Prospective Studies<br/>Urinary Bladder Neoplasms--drug therapy